ISPOR US is moving south this year, taking place in Atlanta, May 5th to 8th. Broadstreet is pleased to be involved in twelve studies being presented on subjects ranging from a systematic literature review of the economic burden of obesity to patient utilities in Duchenne muscular dystrophy.

We are particularly pleased to be presenting some of our own research on using case identifying algorithms in administrative health datasets. In our study, conducted by Broadstreet team members Alexa Bowie, Maria Tinajero, and Christina Qian, we looked at case-identifying algorithms for identifying patients and events in real-world evidence (RWE) studies. Though these algorithms are essential for finding patients for inclusion in RWE studies, few centralized resources exist to support their implementation. We sought to identify and summarize published, validated case-identifying algorithms developed using Canadian administrative health data (as a single-payer health system there is comprehensive, population-level data available to support the development and validation of algorithms). Having found good coverage of Canadian-specific case identifying algorithms across ICD-10 chapters in the study, our intention is to consolidate the findings into a publicly available resource to support the validity and efficiency of future real-world evidence generation (Figure).

The poster about this project, titled “Validated case-identifying algorithms using Canadian administrative health data: A targeted literature review” will be viewable during poster session 5 on Wednesday, May 8th.

Broadstreet Scientific Director Karissa Johnston will also be moderating a panel this year on the value of diagnostic testing when treatment is not available. Panelists include Dr. Richard Rothman, who will share his clinical experience as an ER doctor, Dr. Lon Castle providing a payer perspective and Dr. Lou Garrison discussing the idea of the value of diagnostic information (VODI) and the evaluation of diagnostic tests beyond the current economic evaluation framework.

The panel will take place on May 8th at 10 a.m.

We invite you to check out all our posters:

In Session 1 on Monday, May 6th:
Health state utilities in Duchenne muscular dystrophy (DMD): A longitudinal study using the EQ5D and Health Utilities Index (HUI)
Authors: Shelagh M. Szabo,¹ Ivana F Audhya,2 Andrea Bever,1 Rosie Sun,1 Evelyn Griffin,1 Dave Feeny,3 Dan Malone,4 Peter Neumann,5 Susan T Iannaccone,6 Katherine L Gooch2
¹Broadstreet HEOR, Vancouver, BC, Canada, ²Sarepta Therapeutics, Inc., Cambridge, MA, USA, ³McMaster University, Hamilton, ON, Canada, ⁴The University of Utah, Salt Lake City, UT, USA, ⁵Tufts Medical Center, Boston, MA, USA, ⁶The University of Texas Southwestern, Dallas, TX, USA

Impact of changes in US Medicaid reimbursement for long-acting reversible contraceptives in the immediate postpartum period
Authors: Sarah E Walker,¹ Simone Crespi,² Emilia Kourmaeva,¹ Gursimer Jeet,¹ Greta Lozano-Ortega^2
1Broadstreet HEOR, Vancouver, BC, Canada, ²Organon & Co, Hoboken, NJ, USA

Characterizing the prevalence of metabolic dysfunction-associated steatohepatitis (MASH) among adults ≥65 years of age in the United States (US) using three real-world cohorts
Authors: Yestle Kim,¹ Hannah Rochon,² Christina Qian,² Shelagh M Szabo,² Alina Bogdanov,³ Ni Zeng,³ Rosie Sun,² Mac Bonafede,³ Matthew Davis,⁴ Dominic Nunag,⁴ Jesse Fishman^1
1Madrigal Pharmaceuticals, West Conshohocken, PA, USA, ²Broadstreet HEOR, Vancouver, BC, Canada, ³Veradigm, Chicago, IL, USA, ⁴Medicus Economics, Milton, MA, USA

BoNT-As for adult upper limb spasticity: Cost of treatment and response to therapy in Canadian patients
Authors: Yulia Privolnev,¹ Karissa Johnston,² Evelyn Griffin^2
1Ipsen Biopharmaceuticals, Toronto, ON, Canada, ²Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada

In Session 2 on Monday, May 6th:
Characterizing the experience of caregiving for those with Duchenne muscular dystrophy (DMD): Results from a cross-sectional survey
Ivana F Audhya,¹ Jessica S Dunne,² Shivangi Patel,¹ Shelagh M Szabo,² Michael Friesen,² Katherine L Gooch^1
1Sarepta Therapeutics, Inc., Cambridge, MA, USA, ²Broadstreet HEOR, Vancouver, BC, Canada

In Session 3 on Tuesday, May 7th:
The balancing act of paid work and caregiving in Duchenne muscular dystrophy (DMD): Results from a cross-sectional survey
Shivangi Patel,¹ Jessica S Dunne,² Ivana F Audhya,¹ Shelagh M Szabo,² Andrea Bever,² Katherine L Gooch^1
1Sarepta Therapeutics, Inc., Cambridge, MA, USA, ²Broadstreet HEOR, Vancouver, BC, Canada

The direct economic burden of obesity and obesity-related comorbidities (ORC) in the United States (US): A systematic review
Alison M Bjornson,¹ Megan M Gardner,¹ Bonnie M Donato,² Shelagh M Szabo,¹ Effie Kuti^2
1Broadstreet HEOR, Vancouver, BC, Canada, ²Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA

Characterizing the clinical and economic burden of covid-19 among individuals with immunocompromising conditions in Ontario, Canada – a matched, population-based observational study
Christina Qian,¹ Adrian Nam,² Karissa Johnston,¹ Maria Tinajero,¹ Mackenzie A Hamilton^2
1Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada, ²AstraZeneca Canada, Mississauga, ON, Canada

In Session 4 on Tuesday May 7th:
The current landscape of anti-obesity medication coverage policies and utilization rates in the United States: A targeted literature review
Alison M Bjornson,¹ Effie Kuti,² Megan M Gardner,¹ Shelagh M Szabo,1 Bonnie M Donato^2
1Broadstreet HEOR, Vancouver, BC, Canada, ²Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA

Benefits and barriers to same-day long-acting reversible contraceptive insertion: Evidence and its implications from US settings
Andrew R Kennedy,¹ Simone Crespi,² Gursimer Jeet,¹ Greta Lozano-Ortega^1
1Broadstreet HEOR, Vancouver, BC, Canada, ²Organon & Co, Hoboken, NJ, USA

In Session 5 on Wednesday, May 8th:
Burden of heart failure after hospitalization for myocardial infarction in the United States: A targeted literature review
Alison M Bjornson,¹ Kaiwen Guo,² Fernanda Nagase,¹ Melissa L Woodward,¹ Anny C Wong,² Shelagh M Szabo,¹ Lindsay G Bengtson^2
1Broadstreet HEOR, Vancouver, BC, Canada, ²Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA

Validated case-identifying algorithms using Canadian administrative health data: A targeted literature review
Alexa Bowie,¹ Maria Tinajero,¹ and Christina Qian^1
1Broadstreet HEOR, Vancouver, BC, Canada

If you have questions about any of these projects or how Broadstreet can support the development of your HEOR projects, please get in touch at [email protected].